Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2022
Malaria Consortium is committed to rigorously monitoring and evaluating the performance of its SMC program. It is not only important to demonstrate program coverage by evaluating performance against coverage targets, but also to determine the proportion of children who received a full course of SPAQ in each monthly cycle to assess the degree to which target populations are protected against malaria transmission. The primary objectives of this report are as follows:
- To outline methods employed by Malaria Consortium for monitoring coverage of its philanthropically funded SMC program and quality of SMC delivery in 2022.
- To provide a summary of program coverage estimates and degree of adherence to the program’s implementation standards in 2022.
- To provide recommendations on potential adaptations and further improvement to SMC coverage estimation, household surveys and monitoring and evaluation activities for the coming 2023 campaign.